The Kidney Cancer Association (KCA) will partner with xCures, the AI-driven medical record aggregator and research company, to bring advanced opportunities for clinical trial participation and treatment to kidney cancer patients.
The partnership builds on xCures’ expertise in real-world oncology data to accelerate research advances in kidney cancer. Researchers collaborating with the KCA may access xCures’ database of deidentified, real-time, regulatory-grade clinical data to support their work.
In parallel, patients can contribute their medical records to the database as a way to get involved in research efforts. Through the xCures portal, patients can also access their medical records in a streamlined collection for easier decision making. xCures’ clinical data technology may also help patients find optimal treatment options and potentially match them with appropriate clinical trials.
The KCA/xCures partnership represents a joint effort to support both patients and researchers in an effort to advance kidney cancer science and pursue cures.
# # #
xCures Inc. operates an AI-assisted platform that automatically retrieves medical records from all sites of care. The (unstructured) data is aggregated and organized into a powerful, up-to-date care summary that helps cancer patients get the right therapy at the right time. The platform’s portals, xINFORM for patients and xDECIDE for providers, facilitate treatment option decisions. The research portal, xUTILITY, generates Real-time, Regulatory-grade, Clinical data (RRC) for studies and decentralized trials. For more information, contact [email protected] or visit http://www.xcures.com/patients.
About the Kidney Cancer Association
The Kidney Cancer Association is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer. Founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois, the KCA has grown into an international non-profit organization based in Houston, Texas. The KCA promotes scientific advances through two annual research symposiums and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.
Senior Director of Communications
847.332.1051 ext. 113 | [email protected]